Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ATNM Actinium Pharmaceuticals Inc

0.00 (0.0%)
Pre Market
Last Updated: 04:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Actinium Pharmaceuticals Inc ATNM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 5.26 04:00:00
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
12/01/202317:00EDGAR2Form 8-K - Current report
11/09/202317:09EDGAR2Form ARS - Annual Report to Security Holders
11/09/202317:05EDGAR2Form DEF 14A - Other definitive proxy statements
11/06/202307:30PRNUSActinium Presents Preclinical Data at SITC Demonstrating..
11/02/202316:15PRNUSActinium Pharmaceuticals to Attend Bio-Europe Munich 2023
11/02/202309:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202309:05PRNUSActinium Announces Oral Presentation at ASH Annual Meeting..
10/04/202307:30PRNUSActinium Announces NIH Grant Extension to Advance Clinical..
9/27/202309:05PRNUSActinium Pharma Highlights Abstract Accepted for Poster..
9/07/202308:40PRNUSActinium Pharma Presents Survival Data from Extended..
8/31/202307:00PRNUSActinium Pharma Highlights Three Abstracts Accepted for..
8/21/202307:00PRNUSActinium Pharma Highlights Abstracts Accepted for Oral and..
8/14/202317:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202309:00EDGAR2Form S-3 - Registration statement under Securities Act of..
7/24/202307:00PRNUSActinium Pharma to Present at the 2nd Annual Targeted..
6/26/202307:00PRNUSSNMMI 2023 Annual Meeting Abstract of the Year Awarded to..
6/23/202308:00PRNUSActinium Pharma Highlights Six Abstracts Accepted for Oral..
6/16/202307:00PRNUSActinium Pharma to Present at the Maxim Healthcare Virtual..
6/14/202307:00PRNUSActinium Pharma to Present at the TD Cowen..
6/12/202307:00PRNUSActinium Announces Positive Pivotal Phase 3 SIERRA Trial..
6/07/202307:00PRNUSActinium Pharma Set to Join Russell 2000® and Russell 3000®..
5/22/202307:00PRNUSActinium Pharma Announces Six Abstracts Accepted for Oral..
5/11/202311:18PRNUSActinium Pharma Announces Iomab-B SIERRA Trial Results..
5/10/202307:00PRNUSActinium Pharma to Present at Guggenheim Healthcare Talks..
4/28/202308:00PRNUSActinium Highlights Successful Administration of Targeted..
4/27/202310:36PRNUSActinium Announces Positive Pivotal Phase 3 SIERRA Trial..
12/12/202211:05TRMNJonesTrading Keeps Their Buy Rating on Actinium..
12/09/202209:25TRMNActinium Pharmaceuticals (ATNM) Receives a Buy from B.Riley..

Your Recent History

Delayed Upgrade Clock